Then by using stepwise Cox proportional hazard regression testing, methylation status of RASSF1A was an independent factor affecting the NSCLC patients' survival (RR=1.584, 95%CI: 1.040-2.411, P=0.032). The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.